<DOC>
	<DOCNO>NCT00456040</DOCNO>
	<brief_summary>The purpose study describe characteristic patient amyloidosis severe heart failure evaluate cardiac stem cell transplantation .</brief_summary>
	<brief_title>Characteristics Patients With Amyloidosis &amp; Heart Failure Being Evaluated Heart Transplant</brief_title>
	<detailed_description>Systemic amyloidosis progressive disease lead organ failure death . Treatment improve survival stem-cell transplantation . Unfortunately , patient amyloidosis severe heart failure eligible stem-cell transplantation . The average rate survival patient amyloidosis receive heart transplant decrease . Previous trial raise possibility survival may increase patient amyloidosis , chemotherapy stem-cell transplantation perform heart transplant . We plan review data patient amyloidosis heart failure evaluate heart transplant .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>Patients amyloidosis NYHA class III IV heart failure Patients undergoing heart transplant evaluation Patients le 18 year age Patients unstable pulse blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>amyloidosis</keyword>
	<keyword>heart failure</keyword>
	<keyword>heart transplant</keyword>
	<keyword>stem cell transplant</keyword>
</DOC>